Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Trials of new laser surgery for farsightedness:

This article was originally published in Clinica

Executive Summary

Autonomous Technologies has begun a trial of laser in situ keratomileusis (LASIK) in patients with hyperopia to see if the technique is less painful and offers shorter recovery time than conventional laser surgery. LASIK, in which the surgeon cuts a flap in the cornea, reshapes the tissue underneath using a laser and then replaces the flap, is already widely used in the US for nearsighted patients. The Orlando, Florida-based company has developed a device for tracking the eye and precisely controlling the laser beam.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts